Your browser doesn't support javascript.
loading
Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2-Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat.
Akaihata, Hidenori; Matsuoka, Kanako; Hata, Junya; Harigane, Yuki; Yaginuma, Kei; Endo, Yu; Imai, Hitomi; Matsuoka, Yuta; Onagi, Akifumi; Tanji, Ryo; Honda-Takinami, Ruriko; Hoshi, Seiji; Koguchi, Tomoyuki; Sato, Yuichi; Kataoka, Masao; Uemura, Motohide; Igawa, Yasuhiko; Kojima, Yoshiyuki.
Afiliación
  • Akaihata H; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Matsuoka K; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Hata J; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Harigane Y; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Yaginuma K; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Endo Y; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Imai H; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Matsuoka Y; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Onagi A; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Tanji R; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Honda-Takinami R; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Hoshi S; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Koguchi T; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Sato Y; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Kataoka M; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Uemura M; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
  • Igawa Y; Department of Urology, Nagano Prefectural Shinshu Medical Center, 1332 Suzaka, Nagano 382-8577, Japan.
  • Kojima Y; Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
Int J Mol Sci ; 24(4)2023 Feb 16.
Article en En | MEDLINE | ID: mdl-36835398
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vejiga Urinaria / Receptor PAR-2 / Vejiga Urinaria Hiperactiva / Triptasas / Isquemia Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vejiga Urinaria / Receptor PAR-2 / Vejiga Urinaria Hiperactiva / Triptasas / Isquemia Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Japón